Flixotide 100 Diskus 100 µg/dose · CNK 1221522

Product information

Product name
Flixotide 100 Diskus 100 µg/dose
Pack
60
Active ingredient
CNK Code
1221522
Availability score
9.4 / 10
Historic availability score
Locked

Product properties

CAS code
ATC code
R03BA05
Company
GlaxoSmithKline Pharmaceuticals
Pharmaceutical form
Inhalation powder, pre-dispensed
Ex-factory price
€4.84
Authorisation number
BE198746
GTIN
05400571000617
Delivery mode
M1
Delivery environment
Public
CTI Extended
198746-02

Pharmacist Assessment

Assessment title
Discontinued product — remaining stock available
Assessment description

The commercialization of this product has been stopped (reason: Commercial reasons), but remaining stock is available at wholesalers (score 9.4/10). This stock will not be replenished. Plan the switch to an alternative.

Recommended alternative

Assessment alternative
Flixotide 250 Diskus 250 µg/dose (CNK 1221530) — Score: 9.79/10
Assessment alternative warning
Different strength — dose adjustment required. Consult the physician.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Parallel import available 1

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Adaptation of the treatment is possible
Available
Until 31/07/2026

Composition

2 ingredients

Ingredients
Substance Type Strength CAS
Substance
Fluticasonpropionaat
Type
Active ingredient
Strength
100 ug/{dose}
CAS
80474-14-2
Substance
Lactosemonohydraat
Type
Excipient
Strength
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
90 days
Number of status changes
4
Active supply problems
0
Last change
01/08/2026